Pages that link to "Q37322052"
Jump to navigation
Jump to search
The following pages link to Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis (Q37322052):
Displaying 50 items.
- PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis (Q27001552) (← links)
- Turning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug development (Q27024397) (← links)
- TFPI1 mediates resistance to doxorubicin in breast cancer cells by inducing a hypoxic-like response (Q28539226) (← links)
- Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells. (Q33765419) (← links)
- GPCRs and cancer (Q33828719) (← links)
- Functional role of kallikrein 6 in regulating immune cell survival (Q33862447) (← links)
- Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1). (Q34037992) (← links)
- Gene profiling analysis for patients with oral verrucous carcinoma and oral squamous cell carcinoma (Q34042296) (← links)
- Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy (Q34048965) (← links)
- Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models. (Q34148307) (← links)
- Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis (Q34450747) (← links)
- The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model (Q34503022) (← links)
- Par genes: molecular probes to pathological assessment in breast cancer progression (Q34557771) (← links)
- Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer (Q35070124) (← links)
- Cdc25A regulates matrix metalloprotease 1 through Foxo1 and mediates metastasis of breast cancer cells (Q35139929) (← links)
- Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia (Q35776992) (← links)
- Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics (Q35860717) (← links)
- c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis (Q35887678) (← links)
- Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status (Q35921287) (← links)
- Matrix metalloprotease-1a promotes tumorigenesis and metastasis (Q36097959) (← links)
- Inhibition of tissue factor by ixolaris reduces primary tumor growth and experimental metastasis in a murine model of melanoma (Q36179649) (← links)
- Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis. (Q36322931) (← links)
- Peptide structure stabilization by membrane anchoring and its general applicability to the development of potent cell-permeable inhibitors. (Q36384434) (← links)
- Characterization of PAR1 and FGFR1 expression in invasive breast carcinomas: Prognostic significance. (Q36423991) (← links)
- Matrix metalloproteases and PAR1 activation (Q36542806) (← links)
- Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma (Q36627182) (← links)
- Twist-mediated Epithelial-mesenchymal Transition Promotes Breast Tumor Cell Invasion via Inhibition of Hippo Pathway (Q36814799) (← links)
- Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway (Q37019583) (← links)
- Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination (Q37125854) (← links)
- Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature (Q37364878) (← links)
- Lung cancer with gastrointestinal metastasis - review of theories of metastasis with three rare case descriptions (Q37373798) (← links)
- Coagulation, protease-activated receptors, and viral myocarditis. (Q37619823) (← links)
- Downregulation of MMP1 in MDS-derived mesenchymal stromal cells reduces the capacity to restrict MDS cell proliferation (Q37682247) (← links)
- Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility. (Q37756119) (← links)
- Serine and metalloprotease signaling through PAR1 in arterial thrombosis and vascular injury. (Q37873891) (← links)
- Tissue factor and cell signalling in cancer progression and thrombosis (Q37903955) (← links)
- Targeting proteinase-activated receptors: therapeutic potential and challenges. (Q37972789) (← links)
- Driving transcriptional regulators in melanoma metastasis (Q38017594) (← links)
- Cell surface remodeling by plasmin: a new function for an old enzyme (Q38055477) (← links)
- Protease receptor antagonism to target blood platelet therapies (Q38616508) (← links)
- Platelet-targeted pharmacologic treatments as anti-cancer therapy (Q38657846) (← links)
- Neutrophil elastase and proteinase-3 trigger G protein-biased signaling through proteinase-activated receptor-1 (PAR1). (Q39093865) (← links)
- SIN1 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition (Q39169788) (← links)
- Targeting PAR1: Now What? (Q39338913) (← links)
- Sporamin induce apoptosis in human tongue carcinoma cells by down-regulating Akt/GSK-3 signaling (Q39712359) (← links)
- Pepducins and Other Lipidated Peptides as Mechanistic Probes and Therapeutics (Q40405065) (← links)
- Constitutive K-RasG12D activation of ERK2 specifically regulates 3D invasion of human pancreatic cancer cells via MMP-1. (Q41903918) (← links)
- Down-regulation of PAR1 activity with a pHLIP-based allosteric antagonist induces cancer cell death (Q42066943) (← links)
- Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2. (Q42479614) (← links)
- GPCR Signaling Mediates Tumor Metastasis via PI3Kβ (Q42586240) (← links)